Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019

BackgroundThe exponential growth of the cancer burden attributable to metabolic factors deserves global attention. We investigated the trends of cancer mortality attributable to metabolic factors in 204 countries and regions between 1990 and 2019.MethodsWe extracted data from the Global Burden of Di...

Full description

Bibliographic Details
Main Authors: Yan Zhang, Yuwei Ding, Ning Zhu, Mi Mi, Yier Lu, Jia Zheng, Shanshan Weng, Ying Yuan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1032749/full
_version_ 1797948082678136832
author Yan Zhang
Yuwei Ding
Yuwei Ding
Ning Zhu
Ning Zhu
Mi Mi
Mi Mi
Yier Lu
Yier Lu
Jia Zheng
Shanshan Weng
Ying Yuan
Ying Yuan
Ying Yuan
author_facet Yan Zhang
Yuwei Ding
Yuwei Ding
Ning Zhu
Ning Zhu
Mi Mi
Mi Mi
Yier Lu
Yier Lu
Jia Zheng
Shanshan Weng
Ying Yuan
Ying Yuan
Ying Yuan
author_sort Yan Zhang
collection DOAJ
description BackgroundThe exponential growth of the cancer burden attributable to metabolic factors deserves global attention. We investigated the trends of cancer mortality attributable to metabolic factors in 204 countries and regions between 1990 and 2019.MethodsWe extracted data from the Global Burden of Disease Study (GBD) 2019 and assessed the mortality, age-standardized death rate (ASDR), and population attributable fractions (PAFs) of cancers attributable to metabolic factors. Average annual percentage changes (AAPCs) were calculated to assess the changes in the ASDR. The cancer mortality burden was evaluated according to geographic location, SDI quintiles, age, sex, and changes over time.ResultsCancer attributable to metabolic factors contributed 865,440 (95% UI, 447,970-140,590) deaths in 2019, a 167.45% increase over 1990. In the past 30 years, the increase in the number of deaths and ASDR in lower SDI regions have been significantly higher than in higher SDI regions (from high to low SDIs: the changes in death numbers were 108.72%, 135.7%, 288.26%, 375.34%, and 288.26%, and the AAPCs were 0.42%, 0.58%, 1.51%, 2.36%, and 1.96%). Equatorial Guinea (AAPC= 5.71%), Cabo Verde (AAPC=4.54%), and Lesotho (AAPC=4.42%) had the largest increase in ASDR. Large differences were observed in the ASDRs by sex across different SDIs, and the male-to-female ratios of ASDR were 1.42, 1.50, 1.32, 0.93, and 0.86 in 2019. The core population of death in higher SDI regions is the age group of 70 years and above, and the lower SDI regions are concentrated in the age group of 50-69 years. The proportion of premature deaths in lower SDI regions is significantly higher than that in higher SDI regions (from high to low SDIs: 2%, 4%, 7%, 7%, and 9%). Gastrointestinal cancers were the core burden, accounting for 50.11% of cancer deaths attributable to metabolic factors, among which the top three cancers were tracheal, bronchus, and lung cancer, followed by colon and rectum cancer and breast cancer.ConclusionsThe cancer mortality burden attributable to metabolic factors is shifting from higher SDI regions to lower SDI regions. Sex differences show regional heterogeneity, with men having a significantly higher burden than women in higher SDI regions but the opposite is observed in lower SDI regions. Lower SDI regions have a heavier premature death burden. Gastrointestinal cancers are the core of the burden of cancer attributable to metabolic factors.
first_indexed 2024-04-10T21:37:50Z
format Article
id doaj.art-2e2c623ba22b4f879091fb6f564c7d21
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-10T21:37:50Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-2e2c623ba22b4f879091fb6f564c7d212023-01-19T08:55:39ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-01-011310.3389/fonc.2023.10327491032749Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019Yan Zhang0Yuwei Ding1Yuwei Ding2Ning Zhu3Ning Zhu4Mi Mi5Mi Mi6Yier Lu7Yier Lu8Jia Zheng9Shanshan Weng10Ying Yuan11Ying Yuan12Ying Yuan13Department of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaDepartment of Medical Geriatrics, School of Medicine, The Second Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaDepartment of Medical Oncology (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Sciences, Zhejiang Province, China), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, ChinaZhejiang Provincial Clinical Research Center for CANCER, Hangzhou, Zhejiang, ChinaCancer Center, Zhejiang University, Hangzhou, Zhejiang, ChinaBackgroundThe exponential growth of the cancer burden attributable to metabolic factors deserves global attention. We investigated the trends of cancer mortality attributable to metabolic factors in 204 countries and regions between 1990 and 2019.MethodsWe extracted data from the Global Burden of Disease Study (GBD) 2019 and assessed the mortality, age-standardized death rate (ASDR), and population attributable fractions (PAFs) of cancers attributable to metabolic factors. Average annual percentage changes (AAPCs) were calculated to assess the changes in the ASDR. The cancer mortality burden was evaluated according to geographic location, SDI quintiles, age, sex, and changes over time.ResultsCancer attributable to metabolic factors contributed 865,440 (95% UI, 447,970-140,590) deaths in 2019, a 167.45% increase over 1990. In the past 30 years, the increase in the number of deaths and ASDR in lower SDI regions have been significantly higher than in higher SDI regions (from high to low SDIs: the changes in death numbers were 108.72%, 135.7%, 288.26%, 375.34%, and 288.26%, and the AAPCs were 0.42%, 0.58%, 1.51%, 2.36%, and 1.96%). Equatorial Guinea (AAPC= 5.71%), Cabo Verde (AAPC=4.54%), and Lesotho (AAPC=4.42%) had the largest increase in ASDR. Large differences were observed in the ASDRs by sex across different SDIs, and the male-to-female ratios of ASDR were 1.42, 1.50, 1.32, 0.93, and 0.86 in 2019. The core population of death in higher SDI regions is the age group of 70 years and above, and the lower SDI regions are concentrated in the age group of 50-69 years. The proportion of premature deaths in lower SDI regions is significantly higher than that in higher SDI regions (from high to low SDIs: 2%, 4%, 7%, 7%, and 9%). Gastrointestinal cancers were the core burden, accounting for 50.11% of cancer deaths attributable to metabolic factors, among which the top three cancers were tracheal, bronchus, and lung cancer, followed by colon and rectum cancer and breast cancer.ConclusionsThe cancer mortality burden attributable to metabolic factors is shifting from higher SDI regions to lower SDI regions. Sex differences show regional heterogeneity, with men having a significantly higher burden than women in higher SDI regions but the opposite is observed in lower SDI regions. Lower SDI regions have a heavier premature death burden. Gastrointestinal cancers are the core of the burden of cancer attributable to metabolic factors.https://www.frontiersin.org/articles/10.3389/fonc.2023.1032749/fullglobal burden of disease study (GBD)cancermortalityage standardized rate (ASR)average annual percentage change (AAPC)
spellingShingle Yan Zhang
Yuwei Ding
Yuwei Ding
Ning Zhu
Ning Zhu
Mi Mi
Mi Mi
Yier Lu
Yier Lu
Jia Zheng
Shanshan Weng
Ying Yuan
Ying Yuan
Ying Yuan
Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019
Frontiers in Oncology
global burden of disease study (GBD)
cancer
mortality
age standardized rate (ASR)
average annual percentage change (AAPC)
title Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019
title_full Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019
title_fullStr Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019
title_full_unstemmed Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019
title_short Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019
title_sort emerging patterns and trends in global cancer burden attributable to metabolic factors based on the global burden of disease study 2019
topic global burden of disease study (GBD)
cancer
mortality
age standardized rate (ASR)
average annual percentage change (AAPC)
url https://www.frontiersin.org/articles/10.3389/fonc.2023.1032749/full
work_keys_str_mv AT yanzhang emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT yuweiding emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT yuweiding emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT ningzhu emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT ningzhu emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT mimi emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT mimi emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT yierlu emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT yierlu emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT jiazheng emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT shanshanweng emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT yingyuan emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT yingyuan emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019
AT yingyuan emergingpatternsandtrendsinglobalcancerburdenattributabletometabolicfactorsbasedontheglobalburdenofdiseasestudy2019